Collective scores a 75 on our Value Score. These are the top-ranked GLP-1 deals we'd point you to instead — every one scored on the same six factors, with the teaser-rate traps flagged so you pay the honest lower price.
✓No teaser step-up. A publicly priced program with no quiz-wall - semaglutide from $79 and tirzepatide from $159, one price at every dose - sold beside a longevity menu you should read past.
$79/mo month-to-month on the 1-month plan (flat at every dose; $49/mo only on the 12-month plan)
Save ~94%
!Pricing to watch. The cheapest genuine month-to-month rate on this site outside the house brand — $79 for semaglutide and $109 for tirzepatide, flat at every dose — advertised in a hero that quotes $49, which is the twelve-month tier.
!Pricing to watch. OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.
!Pricing to watch. A physician-led clinic in St. George, Utah offering GLP-1 care in person or by telehealth, quoting an approximate $80 to $135 a month rather than a fixed price per drug.
✓No teaser step-up. Sunlight sells compounded semaglutide and tirzepatide as injections, with its FAQ quoting flat rates of $88 and $157 while its product cards start both at $179.
✓No teaser step-up. VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
!Pricing to watch. Two of the lowest per-month figures in the ranking, held flat at every dose and unusually open about who fills them — but both are annual-plan rates, and no month-to-month price is published at all.
From $74/mo (starting dose, 2-month plan, new patients only, compounded)
Save ~95%
!Pricing to watch. One of the lowest entry prices anywhere, open only to patients new to GLP-1s and paid up front - after which it becomes a $149/mo program, which is the number worth comparing.
⚠FDA warning letter. The FDA issued OrderlyMeds LLC dba OrderlyMeds a warning letter in June 2026. Check it on the FDA database.
Ranked by our Value Score — our editorial judgment per the methodology. “Save” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Assume any provider we list may compensate us — it never changes a Value Score. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.